Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lot-to-lot consistency study of freeze-dried human rabies vaccine (Vero cell) in healthy participants aged 10-50 years
CTR20263422Phase 4Active
- Sponsor
- Jiangsu Kangrun Biotechnology
- Start
- Aug 2026
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 4 trial of Rabies Vaccine (Serum-free Vero Cell) in rabies, sponsored by Jiangsu Kangrun Biotechnology. Started Aug 2026; status: active.
02
Drugs
Rabies Vaccine (Serum-free Vero Cell)
03
Conditions
rabies
Beyond the preview
Go deeper on CTR20263422.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20263422.